Perspective of patients with autoimmune diseases on COVID-19 vaccination – The Lancet

The socioeconomic burden of COVID-19 and pressure on health-care systems can only be reduced by achieving herd immunity against SARS-CoV-2. For herd immunity to be achieved, it has been estimated that, depending on the efficacy of the vaccines employed, approximately 60–100% of the global population needs to be vaccinated.1Anderson RM Vegvari C Truscott J Collyer BS Challenges in creating herd immunity to SARS-CoV-2 infection by mass vaccination. Countries all over the world are developing vaccination strategies, and many have already started vaccinating their populations. However, the rapid development, approval, and release of vaccines against SARS-CoV-2 has led to uncertainties in the population, which might reduce willingness to get vaccinated.2Guidry JPD Laestadius LI Vraga EK Miller CA Perrin PB Burton CW et al.Willingness to